UY39616A - DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES - Google Patents

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES

Info

Publication number
UY39616A
UY39616A UY0001039616A UY39616A UY39616A UY 39616 A UY39616 A UY 39616A UY 0001039616 A UY0001039616 A UY 0001039616A UY 39616 A UY39616 A UY 39616A UY 39616 A UY39616 A UY 39616A
Authority
UY
Uruguay
Prior art keywords
hbv
treatment
induced diseases
infection
dihydropyrimidine derivatives
Prior art date
Application number
UY0001039616A
Other languages
Spanish (es)
Inventor
Xiangjun Deng
Yanping Xu
Gang Deng
Zhiguo Liu
Zhanling Cheng
Yimin Jiang
Chao Liang
Jianping Wu
Linglong Kong
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of UY39616A publication Critical patent/UY39616A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La solicitud describe derivados de dihidropirimidina que son útiles en el tratamiento o la prevención de una infección por VHB o de enfermedades inducidas por VHB, más particularmente de una infección crónica por VHB o de enfermedades inducidas por una infección crónica por VHB, así como aplicaciones farmacéuticas o médicas de estos.The application describes dihydropyrimidine derivatives that are useful in the treatment or prevention of HBV infection or HBV-induced diseases, more particularly chronic HBV infection or chronic HBV-infection induced diseases, as well as pharmaceutical applications. or medical of these.

UY0001039616A 2021-01-29 2022-01-28 DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES UY39616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2021074353 2021-01-29

Publications (1)

Publication Number Publication Date
UY39616A true UY39616A (en) 2022-07-29

Family

ID=80349919

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039616A UY39616A (en) 2021-01-29 2022-01-28 DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES

Country Status (4)

Country Link
AR (1) AR124719A1 (en)
TW (1) TW202246269A (en)
UY (1) UY39616A (en)
WO (1) WO2022161448A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10013126A1 (en) * 2000-03-17 2001-09-20 Bayer Ag New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity
KR102148678B1 (en) 2012-08-24 2020-08-27 선샤인 레이크 파르마 컴퍼니 리미티드 Dihydropyrimidine compounds and their application in pharmaceuticals
CN103664897B (en) 2012-09-01 2018-04-03 广东东阳光药业有限公司 Dihydropyrimidines and its application in medicine
CN103664925B (en) 2012-09-07 2018-01-23 广东东阳光药业有限公司 The Dihydropyrimidines of heteroaryl substitution and its application in medicine
CN103664899B (en) 2012-09-11 2017-06-16 广东东阳光药业有限公司 The Dihydropyrimidines of heteroaryl substitution and its application in medicine
JP2022511819A (en) * 2018-12-20 2022-02-01 ヤンセン ファーマシューティカ エヌ．ベー． How to treat heteroaryldihydropyrimidine derivatives and hepatitis B infections
TW202035412A (en) 2018-12-20 2020-10-01 比利時商健生藥品公司 Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infections
BR112022000971A2 (en) * 2019-07-31 2022-06-07 Janssen Sciences Ireland Unlimited Co Dihydropyrimidine derivatives and their use in the treatment of hbv infection or hbv-induced diseases

Also Published As

Publication number Publication date
TW202246269A (en) 2022-12-01
WO2022161448A1 (en) 2022-08-04
AR124719A1 (en) 2023-04-26

Similar Documents

Publication Publication Date Title
CR20170424A (en) TREATMENT COMBINED WITH A TLR7 AGONIST AND AN INHIBITOR OF THE VHB CAPSULE ASSEMBLY
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
ECSP12012106A (en) ANTIVIRAL THERAPY
CL2008001855A1 (en) Boron-derived condensed cyclic compounds; pharmaceutical composition; and use in the treatment and / or prevention of an infectious disease.
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
ECSP23096498A (en) NOVEL THERAPEUTIC ADMINISTRATION REMAINS AND USES OF THESE
BR112012030641A2 (en) methods and compositions for oral pharmaceutical therapy
CO2017007076A2 (en) Indenyl compounds, pharmaceutical compositions and medical uses thereof
MX2020003464A (en) NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TREATING HEPATITIS B INFECTION.
BR112016027435A2 (en) innovative formulation of meloxicam
BR112017006005A2 (en) pharmaceutical composition, and method of preventing or treating a hiv infection.
MX2021010145A (en) Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases.
BR112017024727A2 (en) cocrystal, pharmaceutical composition, method of treatment of a disease in an individual and production process of a cocrystal
ECSP17019893A (en) ANAMORELIN-BASED MEDICAL TREATMENTS
CY1123696T1 (en) DRUG FOR THE TREATMENT OF DIABETIC FOOT INFECTIONS
BR112022000971A2 (en) Dihydropyrimidine derivatives and their use in the treatment of hbv infection or hbv-induced diseases
DOP2021000039A (en) PROLONGED ADMINISTRATION OF MEDITAN AT NIGHT FOR THE PREVENTION OF MIGRAINE
UY39550A (en) CONDENSED HETEROCYCLIC DERIVATIVES
EP3814326A4 (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases
UY39504A (en) COMPOSITION FOR THE TREATMENT OF A VASCULAR DISEASE, COMPOSITION FOR THE PREVENTION OF A VASCULAR DISEASE, COMPOSITION FOR THE TREATMENT OF HYPERTENSION, AND COMPOSITION FOR THE PREVENTION OF HYPERTENSION
UY39616A (en) DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES
PH12018500450A1 (en) Immunity enhancing agent for cancer by allergin-1 antagonist
BR112022001564A2 (en) DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USES IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES
CL2020001638A1 (en) Nucleic acid molecule for the reduction of papd5 and papd7 mRNA in the treatment of hepatitis b infection. (divisional request 202000945)
IT1396915B1 (en) DIETYL- [6- (4-HYDROXICARBAMYL-PHENYL-CARBAMYLOSSIMETHYL) -NAFTALEN-2-IL-METHYL] -AMMONIUM CHLORIDE AND OTHER DERIVATIVES OF N-HYDROXY-BENZAMID FOR THE USE IN THE TREATMENT OF HIV INFECTIONS.